Tacrus
FDA Label NDC 82160-124

13 label sections · Submitted to the FDA by Pella Pharmaceuticals Co. Ltd · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Pella Pharmaceuticals Co. Ltd for the product Tacrus (NDC 82160-124). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding composition, indications, contraindications, precautions while taking tacrus ®, lactation, pregnancy, drug interactions, dosage and administration, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.